Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10023606 19-nor neuroactive steroids and methods of use thereof

Patent 10023606 was granted and assigned to SAGE Therapeutics on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100236060

Patent Inventor Names

Boyd L. Harrison0

Francesco G. Salituro0

Gabriel Martinez Botella0

Richard Thomas Beresis0

Albert Jean Robichaud0

Date of Patent

July 17, 2018

Patent Application Number

152731250

Date Filed

September 22, 2016

Patent Citations Received

‌

US Patent 12083131 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 11571432 Compositions that preferentially potentiate subtypes of GABA

‌

US Patent 10857163 Compositions that preferentially potentiate subtypes of GABA

‌

US Patent 11945836 Compositions and methods for treating CNS disorders

‌

US Patent 12060386 Compositions and methods for treating CNS disorders

Patent Primary Examiner

‌

Yevgeny Valenrod

Patent abstract

Provided herein are 3,3-disubstituted 19-nor-steroidal compounds according to Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10023606 19-nor neuroactive steroids and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API